Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

ZappRx announces new prior authorization partnership with PARx Solutions

ZappRx
Posted on: 29 Nov 16

PR Newswire

BOSTON, Nov. 29, 2016

BOSTON, Nov. 29, 2016 /PRNewswire/ -- ZappRx (zapprx.com), a digital specialty prescribing platform focused on increasing patient access to specialty therapy, announced a partnership with PARx Solutions (parxsolutions.com), a leader in helping prescribers manage prescription prior authorizations (PA). This strategic partnership combines ZappRx's expertise in automating the specialty drug prescribing process with PARx's expertise in helping prescribers overcome challenges experienced during prior authorization that lead to delays in patients receiving their medications.

"A partnership with PARx Solutions offers providers a uniform and simplified prior authorization service," said Karen Tirozzi, Vice President of Solutions at ZappRx. "Providers who use our platform will experience consistent electronic steps to get PAs approved while generating specialty prescriptions."

Founded in 2008 and based in Burlington, Massachusetts, PARx Solutions has been successful in providing their PA system throughout physician offices across the nation. To date, tens of thousands of providers rely on PARx Solutions to process prior authorizations for more than 70 prescription medications.

"Partnering with ZappRx is a natural fit for PARx Solutions. We believe their technology platform is very effective for specialty medication management and feel strongly that our PA service meets an important need for specialty medication prescribers," said Dan Rubin, President and CEO of PARx Solutions. "Prescribers and pharmacists who manage specialty drugs experience time-consuming and frustrating challenges that hinder patient care. It's our goal to eliminate these barriers by providing a simplified process."

PARx's "white glove" PA service will be available via ZappRx's platform. As a result, providers can populate information for the PA at the same time they prescribe a specialty drug, allowing for a faster process to get the prescription sent. ZappRx in partnership with PARx provides a single, digital platform to track the status of prescribed specialty drugs. PARx's proprietary PA format has proven to be effective at generating high approval rates and more timely PA resolutions.

About ZappRx
ZappRx is modernizing and simplifying the way specialty medications are managed. The company provides a secure, collaborative online platform that allows patients, physicians and pharmacists to work together to improve patients' access to treatment, delivering medicine faster, with fewer hassles and greater transparency. ZappRx is on the web at ZappRx.com. Follow ZappRx on Twitter at twitter.com/zapprx.

Media Contact:
Emily Thompson, Marketing Manager
emily.thompson@zapprx.com
617.844.0989

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zapprx-announces-new-prior-authorization-partnership-with-parx-solutions-300369594.html

SOURCE ZappRx

PR Newswire
www.prnewswire.com

Last updated on: 29/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.